LymeNet Flash: More on Ketek and Liver Problems

LymeNet on Facebook

LymeNet on Twitter

Follow @LymeDiseaseNet

The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive

The Lyme Disease Network is a non-profit organization funded by individual donations.

»	LymeNet Flash » Questions and Discussion » Medical Questions » More on Ketek and Liver Problems

UBBFriend: Email this page to someone!

Author

Topic: More on Ketek and Liver Problems

Mathias
Frequent Contributor (1K+ posts)
Member # 5298

posted

PARIS, May 19 (Reuters) - French drug maker Sanofi-Aventis confirmed on Friday that it was in talks with the U.S. Food and Drug Administration about its antibiotic Ketek, following a report the regulator wanted a warning label on the drug.

The Wall Street Journal, citing an internal FDA memo, reported that Ketek had been linked to 12 cases of liver failure, including four deaths, and that the FDA was recommending that the company put a warning label on the drug.

"Sanofi continues to believe that Ketek is safe and effective," said a company spokesman in Paris. "We are in talks with the FDA to evaluate secondary effects on the liver; and, as we are in discussions, we are not going to start commenting on these figures."

He said that all secondary effects were reported to the FDA, and that talks on labeling had been going on for several months. He said that the company did not have a copy of the memo cited by the newspaper.

The Wall Street Journal said that U.S. lawmakers have questioned the FDA's 2004 approval of the drug, amid charges of faulty data from one of the trials.

Ketek, which was approved to treat respiratory infections, drew renewed scrutiny in January, when researchers reported that three patients using the drug developed severe liver damage and that one died.

The FDA rejected the drug in 2001 and 2003, asking for more safety information.

Sanofi shares were down 0.5 percent, at 73.10 euros, by 1247 GMT.

--------------------
Mathias

Posts: 1250 | From New Jersey | Registered: Feb 2004 | IP: Logged |

treepatrol
Honored Contributor (10K+ posts)
Member # 4117

posted

I held off for over a year and a half from taking this one then I took it for 2 months nothing like putting the genie back in the bottle. ah crud

--------------------
Do unto others as you would have them do unto you.
Remember Iam not a Doctor Just someone struggling like you with Tick Borne Diseases.

Newbie Links

Posts: 10564 | From PA Where the Creeks are Red | Registered: Jun 2003 | IP: Logged |

AZURE WISH
Frequent Contributor (1K+ posts)
Member # 804

posted

I am glad they are just trying to put a warning label on it and not trying to take it off the market. [woohoo]

It would be horrible if they took it off the market.....at least for me. [bonk]

--------------------
multiple chemical sensitvity group:
http://www.lymefriends.com/group/multiplechemicalsensitivities

Group for artists. All media welcome:
http://www.lymefriends.com/group/creativecorner

http://groups.yahoo.com/group/Lyme_Artist

Posts: 3860 | From nj,usa | Registered: Mar 2001 | IP: Logged |

luvs2ride
Frequent Contributor (1K+ posts)
Member # 8090

posted

Which is more dangerous? The tick or the cure?

I'll stick to safer methods.

--------------------
When the Power of Love overcomes the Love of Power, there will be Peace.

Posts: 3038 | From america | Registered: Oct 2005 | IP: Logged |

Printer-friendly view of this topic

The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA
http://www.lymenet.org/